Company profile for Medlab Clinical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Medlab has a portfolio of novel therapeutics solutions (both over the counter and prescription), with the lead product for pain management advancing towards Phase III trials. Medlab also has a patented drug delivery platform called NanoCelle® in the market that improves drug solubility issues and enables faster absorption. The unique platform supports Medlab’s mission to improve patients' quality of life and health out...
Medlab has a portfolio of novel therapeutics solutions (both over the counter and prescription), with the lead product for pain management advancing towards Phase III trials. Medlab also has a patented drug delivery platform called NanoCelle® in the market that improves drug solubility issues and enables faster absorption. The unique platform supports Medlab’s mission to improve patients' quality of life and health outcomes globally. Together, we will deliver more for human health and beyond.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
11-13 Lord St Botany Building A, Unit A5 – A6, Botany Quarter Nsw,
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/01/12/2587785/0/en/MEDLAB-ANNOUNCES-FAVOURABLE-INTERIM-READOUT-OF-NANABIS-REAL-WORLD-EVIDENCE-RWE-MEDCARE-STUDY.html

GLOBENEWSWIRE
12 Jan 2023

https://www.pharmaceutical-technology.com/news/medlab-grant-nasal-vaccine/

PHARMACEUTICAL-TECHNOLOGY
17 Jan 2022

https://www.globenewswire.com/news-release/2022/01/14/2367257/0/en/Medlab-ASX-MDC-receives-Government-grant-to-apply-NanoCelle-to-an-RNA-nasal-vaccine-in-collaboration-with-University-of-NSW-UNSW-and-Macquarie-University-MQ-to-fight-COVID-19-futur.html

GLOBENEWSWIRE
14 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty